Assoc. Prof. Dr. Zongjunlin Liu | Tumor | Best Researcher Award

Liu Zongjunlin is an associate professor of dermatology and venereology at the Affiliated Hospital of Southwest Medical University. He holds a doctorate in physiology from Xiamen University and has a strong background in clinical practice, teaching, and research. His work focuses on skin tumors, cosmetic dermatology, and innovative medical technologies. He has published influential papers in high-impact journals, secured research projects and patents, and actively mentors undergraduate and graduate students. Recognized with multiple academic awards and patient honors, he combines medical expertise, innovation, and leadership to advance both patient care and medical education.

Education

Liu Zongjunlin pursued his medical studies with determination and steady progress through different stages of higher education. He began his academic journey at North Sichuan Medical College, where he completed his bachelor’s degree in medicine. He continued to deepen his expertise at Southwest Medical University, earning a master’s degree with a focus on medical sciences. His academic path culminated at Xiamen University, where he was awarded a doctorate in physiology, strengthening his foundation in medical research and advanced clinical knowledge.

Experience

After completing his doctorate, Liu Zongjunlin joined the Affiliated Hospital of Southwest Medical University. He has been appointed internally as an associate professor in the Department of Dermatology and Venereology. In his clinical practice, he has played a key role in patient care, contributing to the admission and treatment of a large number of inpatients and outpatients. He also assisted his department in the development of new medical technologies and participated in the improvement of specialist ward and clinic management. His involvement in both teaching and management has further enhanced his contribution to medical education and hospital development.

Awards and Recognition

Liu Zongjunlin’s dedication to medicine and education has been widely recognized. He has received multiple honorary banners from patients and peers as a token of appreciation for his medical service. His teaching efforts have been acknowledged through successful guidance of students in provincial-level innovation projects. In academic circles, he has won several awards for his participation in national and provincial speech competitions and poster presentations, achieving high ranks that reflect his strong communication skills and professional expertise.

Skills and Expertise

Liu Zongjunlin demonstrates well-rounded skills that encompass medical treatment, teaching, scientific research, and departmental management. Clinically, he has shown innovation by assisting in the development of new dermatological technologies. In teaching, he has guided undergraduate and graduate students, helping them succeed in both classroom learning and research projects. In research, he has published high-quality scientific papers in internationally recognized journals, secured multiple funded projects, and obtained national patents. His organizational abilities are evident in his assistance with departmental management, construction of clinical services, and participation in leadership training.

Research Focus

Liu Zongjunlin’s research interests lie in the field of dermatology and venereology, with a particular emphasis on skin tumors, cosmetic dermatology, and clinical applications of innovative technologies. His studies have been published in top-tier scientific journals with high impact, underscoring the relevance and influence of his work. By bridging clinical practice and research, his contributions not only advance medical knowledge but also bring direct benefits to patient care. His patents further highlight his drive for innovation and his vision to integrate research into practical solutions for medical challenges.

Publication

Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
Authors: Yu Rao, Zheng Lei, Siyu Chen, Xiaoping Zhu, Zongzhe Jiang, Yang Xu, Xia Xiong, Yongmei Liao, Xiqian Chen, Qian Tang, Zongjunlin Liu, Changqiang Li
Journal: Scientific Reports

Conclusion

Liu Zongjunlin has established himself as a promising physician, educator, and researcher in dermatology and venereology. His academic achievements, clinical expertise, teaching dedication, and innovative research collectively reflect a professional of exceptional caliber. Through his strong commitment to patient care, his mentorship of young medical students, and his pioneering research, he has made meaningful contributions to both medicine and medical education. His trajectory shows clear potential for continued growth as a leader in his field.

Prof. Dr. Dengke Bao | Tumor biology | Best Researcher Award

Dengke Bao, Ph.D., is a professor, Ph.D. supervisor, and Deputy Dean at the School of Pharmacy, Henan University. He is a recipient of the Excellent Youth Fund Project of the Henan Natural Science Foundation and the 2022 China Postdoctoral Science Foundation Funding. His research focuses on mitochondria-related mechanisms in tumorigenesis, cancer progression, and immune regulation. He has published 20+ SCI-indexed papers in top journals like Oncogene and Cell Death & Disease and serves as an editorial member for Scientific Reports. His work provides new insights into tumor microenvironment remodeling and drug resistance in cancer therapy.

Prof. Dr. Dengke Bao | Henan University | China

👨‍🏫Experience

Currently serving as the Deputy Dean of the School of Pharmacy at Henan University, Dengke Bao has played a pivotal role in advancing molecular diagnostics and therapy. He is also the Deputy Director of the Henan Engineering Research Center for Molecular Diagnosis and Therapy of Esophageal Cancer and the Director of the Laboratory of Biomarkers and Liquid Biopsy in Kaifeng. His work has significantly contributed to understanding mitochondria-related mechanisms in tumorigenesis, cancer progression, and tumor immune regulation.

🏆Awards and Recognitions

Dengke Bao has been honored with numerous awards, including the Excellent Youth Fund Project of the Henan Natural Science Foundation and recognition as a Young Core Instructor of Henan. He was also a recipient of the 2022 China Postdoctoral Science Foundation Funding, highlighting his exceptional contributions to the field of oncology research.

💡Skills and Certifications

With a deep expertise in tumor biology and the tumor microenvironment, Dengke Bao specializes in investigating mitochondrial damage-associated molecular patterns (DAMPs) and their role in inflammatory responses and cancer therapy resistance. His research combines molecular biology, oncology, and immunology to uncover new therapeutic strategies for hepatocellular carcinoma (HCC) and other malignancies.

🔬 Research Focus

Dengke Bao’s research is centered on understanding how mitochondrial damage-associated molecular patterns influence the tumor microenvironment and immune regulation. His groundbreaking study demonstrated that sorafenib treatment in HCC induces the release of mitochondrial DNA into the tumor microenvironment, promoting M2 macrophage polarization through TLR9 activation and enhancing sorafenib resistance. His findings offer a new perspective on targeting mitochondrial DAMPs to reprogram tumor-associated macrophages, providing novel strategies to improve therapeutic efficacy and overcome drug resistance in cancer treatment.

📚 Publications and Editorial Roles

Dengke Bao has authored over 20 SCI-indexed papers as a first or corresponding author in high-impact journals, including Oncogene, Journal of Experimental & Clinical Cancer Research, and Cell Death & Disease. He also serves as an editorial member for Scientific Reports, further solidifying his influence in the field of cancer research.

🌎Conclusion

Given his exceptional research contributions, leadership, and impact in oncology, Dengke Bao is a highly suitable nominee for the Research for Best Researcher Award. His work is not only innovative but also holds great promise for improving cancer treatment and patient outcomes, making him a deserving recipient of this prestigious recognition.

📖Publications

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway
- Authors: J. Lei, Q. Zhu, J. Guo, D. Bao, R. Guo
- Journal: Journal of Translational Medicine, 2024
Tenofovir disoproxil fumarate mediates neuronal injury by inducing neurotoxicity
- Authors: X. Yang, J. Zhang, Y. Cheng, H. Liu, D. Bao
- Journal: European Journal of Clinical Microbiology and Infectious Diseases, 2023
PRRSV infection activates NLRP3 inflammasome through inducing cytosolic mitochondrial DNA stress
- Authors: H. Li, X. Yang, Y. Song, B. Wan, D. Bao
- Journal: Veterinary Microbiology, 2023